Each individual PDUFA reauthorization generates a “have to pass” legislative auto on which marketplace can concentration its Strength and lobbying efforts, which Congress ought to then think about and vote on in just a confined timeframe, constraining its ability to considerably revise the commitments resulting from FDA-marketplace negotiation.